Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Wegovy
Wegovy
Page 3 of 6
Health
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
By
Lindsey Leake
October 10, 2024
Finance
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
By
Greg McKenna
October 7, 2024
Health
Ozempic may help manage opioid addiction: study
By
Naomi Kresge
and
Bloomberg
September 25, 2024
Health
Elon Musk and Bernie Sanders say they agree on one thing—cheaper Ozempic
By
Christiaan Hetzner
September 25, 2024
Politics
Bernie Sanders grills Ozempic maker over high prices, accuses company of endangering lives
By
Madison Muller
,
Naomi Kresge
,
Riley Griffin
and
Bloomberg
September 24, 2024
Health
Novo Nordisk CEO takes aim at U.S. healthcare as he defends Ozempic pricing to Bernie Sanders
By
Ryan Hogg
September 24, 2024
Health
Roche stock is falling after report its Wegovy challenger is causing patients to vomit
By
Naomi Kresge
and
Bloomberg
September 12, 2024
Health
Wegovy reduced Covid deaths in obese patients, study finds
By
Madison Muller
and
Bloomberg
August 30, 2024
Retail
Secondhand luxury fashion thrives as Ozempic users purge their closets
By
Sasha Rogelberg
August 29, 2024
Retail
The Mars-Kellanova merger bolsters them against 2 big threats—inflation and Ozempic
By
Sasha Rogelberg
August 14, 2024
Health
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By
Alexa Mikhail
August 14, 2024
Health
Wegovy is finally more widely available—and it’s bad news for Novo Nordisk’s profits
By
Bloomberg
August 7, 2024
Health
How Denmark got homegrown giant Novo Nordisk to lower Ozempic prices
By
Arthur Allen
and
KFF Health News
August 7, 2024
Commentary
I’m an obesity medicine doctor and I’ve been on weight-loss drugs like Ozempic for a decade. Here’s why I think they aren’t a fad
By
Angela Fitch
July 30, 2024
Finance
Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By
Prarthana Prakash
July 29, 2024
Most Popular
Success
At 18, doctors gave him three hours to live. He played video games from his hospital bed—and now, he’s built a $10...
By
Preston Fore
Investing
Baby boomers have now 'gobbled up' nearly one-third of America's wealth share, and they're leaving Gen Z and...
By
Sasha Rogelberg
Economy
‘Be careful what you wish for’: Top economist warns any additional interest rate cuts after today would signal the...
By
Eva Roytburg